CLINICAL_TRIALS
trial_result
· 2016-02-02
Clinical Trial Update: REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation [Phase 2]
Summary
Phase 2 trial update for REVOLUTION (WFCC-133) evaluating treatment of paroxysmal atrial fibrillation; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Biosense Webster, Inc. | Conditions: Paroxysmal Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2016-02-02